| C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia? B Basina, K Bielosludtseva, T Pertseva, T Kirieieva, M Krykhtina, ... European Respiratory Journal 58 (suppl 65), 2021 | 9 | 2021 |
| Lung vessels thrombosis in hospitalized patients with community-acquired pneumonia: role of endothelial function, hemostasis, fibrinolysis and inflammation on different phases … MA Krykhtina, KO Bielosludtseva, LA Botvinikova, NM Matikina Wiad Lek 8, 1463-1465, 2019 | 6 | 2019 |
| Современный взгляд на фармакотерапию инфекций нижних дыхательных путей: место макролидов ТА Перцева, ТВ Киреева, МА Крыхтина Украинский пульмонологический журнал 3, 49-55, 2015 | 6 | 2015 |
| Diagnostic role of systemic inflammation, blood coagulation and padua prediction score in lung thrombosis risk estimation in hospitalized patients with community-acquired pneumonia T Pertseva, T Kirieieva, M Krykhtina, K Bielosludtseva, K Dyagovets Wiadomości Lekarskie 2, 149-153, 2019 | 5 | 2019 |
| Community-aquired pneumonia on the background of coronaviral disease (COVID-19): principles of diagnostics and determination of risk factors of pathological process aggravation TA Pertseva, KO Bielosludtseva, TV Kirieieva, LI Konopkina, MA Krykhtina, ... Medicni perspektivi 25 (3), 50-61, 2020 | 4 | 2020 |
| Fibrinogen like the predictor of COVID-19 pneumonia progression B Basina, K Bielosludtseva, T Pertseva, T Kirieieva, M Krykhtina, ... European Respiratory Journal 58 (suppl 65), 2021 | 3 | 2021 |
| Does diffusion ability of lungs return to normal after COVID-19? M Krykhtina, N Habshydze, L Konopkina, T Pertseva, L Botvinikova European Respiratory Journal 62 (suppl 67), 2023 | 2 | 2023 |
| Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features O Shchudro, K Bielosludtseva, T Pertseva, L Konopkina, M Krykhtina, ... European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts) D Koval, T Pertseva, L Konopkina, K Bielosludtseva, M Krykhtina European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS) K Bielosludtseva, K Fugol, M Krykhtina, O Popova European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| Lymphocyte-to-monocyte ratio (LMR) as a predictor of COVID-19 pneumonia progression D Koval, T Pertseva, L Konopkina, K Bielosludtseva, M Krykhtina European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| Прогнозування тромботичних ускладнень у хворих на негоспітальну пневмонію за даними багатовимірного аналізу тяжкості, системного запалення, стану ендотеліальної функції та … ТО Перцева, КО Бєлослудцева, МА Крихтіна Інфузія & Хіміотерапія= Инфузия & Химиотерапия= Infusion & Chemotherapy 3, 12-17, 2021 | 2 | 2021 |
| Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia K Bielosludtseva, T Pertseva, T Kirieieva, M Krykhtina European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| COVID-19 as endothelial dysfunction trigger N Habshydze, T Pertseva, L Konopkina, Y Hyba, M Krykhtina European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| The features of thrombogenesis in COVID-19-associated pneumonia compared to bacterial pneumonia: the key role of fibrinolysis K Bielosludtseva, M Krykhtina, K Dyahovets European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| Comparison of cardiac biomakers predictive role in COVID-19 pneumonia M Krykhtina, K Bielosludtseva, O Shchudro, L Konopkina European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| Influence of lung impairment on onset of pulmonary hypertension in patients with COVID-19-associated pneumonia M Krykhtina, K Bielosludtseva, K Lyudmila, B Larysa, S Olha European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| Forecasting thrombotic complications in patients with community acquired pneumonia according to multidimensional analysis of severity, systematic inflammation, endothelial … TO Pertseva, KO Bielosludtseva, MA Krykhtina Infusion & Chemotherapy, 12-17, 2021 | 1 | 2021 |
| Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression D Koval, L Konopkina, K Bielosludtseva, M Krykhtina European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| What is the best biomarker of COVID-19 pneumonia progression? K Bielosludtseva, T Pertseva, T Kirieieva, B Basina, N Krabchenko, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
L.I.Konopkina | Л.И.Конопкина | Л.І.Ко...Днепропетровская медицинская академияVerified email at dsma.dp.ua
